DC Chemicals Limited
China
Product Name: Doxorubicinol hydrochloride
Price: ￥Inquiry/1g
Purity: 98.9%
Stocking Period: 1 Day
Contact: Tony Cao

63950-05-0

63950-05-0 structure

63950-05-0 structure

Name: Doxorubicinol hydrochloride
Chemical Name: 13-Dihydroadriamycin hydrochloride
CAS Number: 63950-05-0
Molecular Formula: C₂₇H₃₂ClNO₁₁
Molecular Weight: 581.99600
Catalog: Research Areas Cancer
Create Date: 2017-06-10 02:35:58
Modify Date: 2024-01-09 06:59:06
Doxorubicinol hydrochloride (13-Dihydroadriamycin hydrochloride) is a secondary alcohol metabolite of Doxorubicin[1].

Name	13-Dihydroadriamycin hydrochloride

Description	Doxorubicinol hydrochloride (13-Dihydroadriamycin hydrochloride) is a secondary alcohol metabolite of Doxorubicin[1].
Related Catalog	Research Areas >> Cancer
In Vitro	Doxorubicinol hydrochloride is produced by a two-electron, NADPH-dependent reduction of the Doxorubicin side-chain carbonyl group (C13) to a secondary alcohol[1]. Doxorubicinol hydrochloride has been shown to have significantly lower DNA binding activity as compared to DOX. Moreover, while Doxorubicinol hydrochloride is retained in the cytoplasm or lysosomes, Doxorubicin is mainly accumulated in the nucleus[1].
In Vivo	In vivo, in tumor-bearing mice, Nilotinib, acting as ABCB1 inhibitor, is found to increase the accumulation of Doxorubicin and Doxorubicinol hydrochloride in cancer tissues. This implies that weaker anticancer activity of Doxorubicinol hydrochloride may be related to its increased affinity to ABC transporters, thus leading to a lower intracellular concentration of the agent[1]. In comparison with wild-type mice, the terminal half-life and the area under the plasma concentration-time curve of Doxorubicin in mdr1a(-/-) mice are 1.6- and 1.2-fold higher respectively. The retention of both Doxorubicin and its metabolite Doxorubicinol hydrochloride in the hearts of mdr1a(-/-) mice is substantially prolonged[2].
References	[1]. Kamil Piska, et al. Metabolic carbonyl reduction of anthracyclines - role in cardiotoxicity and cancer resistance. Reducing enzymes as putative targets for novel cardioprotective and chemosensitizing agents. Invest New Drugs. 2017 Jun;35(3):375-385. [2]. J van Asperen, et al. Increased accumulation of doxorubicin and doxorubicinol in cardiac tissue of mice lacking mdr1a P-glycoprotein. Br J Cancer. 1999 Jan;79(1):108-13.

Density	1.61g/cm3
Boiling Point	828.7ºC at 760 mmHg
Melting Point	188-192ºC
Molecular Formula	C₂₇H₃₂ClNO₁₁
Molecular Weight	581.99600
Flash Point	455ºC
Exact Mass	581.16600
PSA	209.23000
LogP	1.29540
Index of Refraction	1.716

CHEMICAL IDENTIFICATION

RTECS NUMBER :: QI9295800

CHEMICAL NAME :: 5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosy l)oxy)-8-(1,2- dihydroxyethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy -1-methoxy-, hydrochloride

CAS REGISTRY NUMBER :: 63950-05-0

LAST UPDATED :: 198406

DATA ITEMS CITED :: 1

MOLECULAR FORMULA :: C27-H31-N-O11.Cl-H

MOLECULAR WEIGHT :: 582.05

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

MUTATION DATA

TYPE OF TEST :: DNA damage

TEST SYSTEM :: Mammal - species unspecified Lymphocyte

DOSE/DURATION :: 52 umol/L

REFERENCE :: FRPSAX Farmaco, Edizione Scientifica. (Casella Postale 227, 27100 Pavia, Italy) V.8-43 1953-88 For publisher information, see FRMCE8 Volume(issue)/page/year: 32,315,1977